You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 70677-0094


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 70677-0094

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 70677-0094

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. It includes the labeler code, product code, and package code, providing detailed information about the drug product, its manufacturer, and its packaging[1][5].

Identifying the Drug

The NDC 70677-0094 corresponds to a specific drug product. To proceed with the analysis, one would typically look up this NDC in the FDA's National Drug Code Directory or other pharmaceutical databases. However, without direct access to real-time databases, we can infer general trends and factors that influence drug pricing.

Market Trends in the Pharmaceutical Industry

The pharmaceutical market is expected to grow significantly, with a projected Compound Annual Growth Rate (CAGR) of 9% through 2030. This growth is driven by increasing demand for prescription drugs, advancements in technology, and the expanding global population[4].

Factors Influencing Drug Prices

Several factors influence the pricing of pharmaceutical products:

Regulatory Environment

Changes in regulatory policies can significantly impact drug prices. For example, the Medicare Drug Price Negotiation Program, initiated under the Inflation Reduction Act, aims to reduce drug prices for Medicare beneficiaries by negotiating prices with drug manufacturers. These negotiated prices are adjusted annually based on the Consumer Price Index (CPI-U)[2].

Competition and Market Dynamics

The presence of generic or biosimilar alternatives can reduce prices by increasing competition. Additionally, market demand and the availability of therapeutic alternatives play crucial roles in determining drug prices.

Technological Advancements

The adoption of artificial intelligence (AI) and other health technologies is transforming the pharmaceutical industry. AI can help in reducing development costs and improving the efficiency of clinical trials, which could eventually lead to lower drug prices[3].

External Data and AI Models

Pharmaceutical companies are increasingly using external data to train internal data science models, including large language models (LLMs). This trend can help in better forecasting market demand and optimizing pricing strategies[3].

Price Projections

Current Pricing

To project future prices, one must first understand the current pricing landscape. For NDC 70677-0094, the current price would need to be retrieved from up-to-date databases or pharmaceutical pricing resources.

Future Price Adjustments

Given the regulatory environment, prices for drugs under the Medicare Drug Price Negotiation Program will be adjusted annually based on the CPI-U. For other drugs, prices may fluctuate based on market competition, technological advancements, and changes in demand.

Example of Price Adjustment

For instance, if a drug like Januvia, which had a list price of $527 for a 30-day supply in 2023, was negotiated down to $113 under the Medicare program, this represents a significant reduction. Similar adjustments could be anticipated for other drugs, depending on their inclusion in such programs and market conditions[2].

Case Study: Impact of Negotiated Prices

The Medicare Drug Price Negotiation Program provides a clear example of how negotiated prices can impact the market. For drugs selected in the first cycle of negotiations, the negotiated prices will apply as long as the drug remains in the program, with annual adjustments based on the CPI-U. This model can serve as a benchmark for understanding potential price reductions in other segments of the pharmaceutical market[2].

Key Takeaways

  • Regulatory Impact: Changes in regulatory policies, such as the Medicare Drug Price Negotiation Program, can significantly reduce drug prices.
  • Market Dynamics: Competition from generic or biosimilar alternatives and changes in market demand influence drug prices.
  • Technological Advancements: The use of AI and external data can help in optimizing pricing strategies and reducing development costs.
  • Price Adjustments: Prices are likely to be adjusted annually based on inflation and other market factors.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique, three-segment number that identifies a drug product, its manufacturer, and its packaging. It is used by the FDA to track and regulate drug products.

Q: How do regulatory changes impact drug prices? A: Regulatory changes, such as the Medicare Drug Price Negotiation Program, can significantly reduce drug prices by negotiating lower prices with manufacturers.

Q: What role does AI play in the pharmaceutical industry? A: AI is increasingly used in the pharmaceutical industry to optimize clinical trials, reduce development costs, and improve pricing strategies.

Q: How are drug prices adjusted over time? A: Drug prices can be adjusted annually based on inflation (CPI-U) and other market factors such as changes in demand and competition.

Q: What are some factors that influence drug pricing? A: Factors include regulatory policies, market competition, technological advancements, and changes in demand.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Medicare Drug Price Negotiation Program - CMS
  3. 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch - Intelligencia.ai
  4. Latest drug prices and trends for NDC 00054-0319 - DrugPatentWatch
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.